AYTU BIOPHARMA INC (AYTU) Stock Analyst Earnings Estimates
NASDAQ:AYTU - Nasdaq - US0547548588 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 96.7M 47.41% | 107.4M 11.07% | 81.002M -24.58% | 68.445M -15.50% | 74.018M 8.14% | 75.397M 1.86% | 123.73M 64.10% | 131.89M 6.60% | 141.07M 6.96% | |
| EBITDA YoY % growth | -24.15M 16.72% | -2.58M 89.32% | 5.383M 308.64% | 15.333M 184.84% | 17.067M 11.31% | 22.801M 33.60% | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.4M 9.95% | -11.4M 66.86% | -2.889M 74.66% | 1.977M 168.43% | 15.834M 700.91% | 15.856M 0.14% | -1.734M -110.94% | 1.122M 164.71% | 4.692M 318.18% | |
| Operating Margin | -35.57% | -10.61% | -3.57% | 2.89% | 21.39% | 21.03% | -1.40% | 0.85% | 3.33% | |
| EPS YoY % growth | -76.20 -2,237.42% | -5.03 93.40% | -2.86 43.14% | 0.73 125.68% | 1.40 90.28% | 1.42 1.46% | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.19 137.27% | 0.53 164.68% |
| Revenue Q2Q % growth | 14.014M -22.11% | 20.981M 16.72% |
| EBITDA Q2Q % growth | 2.18M -46.93% | 8.108M 20.24% |
| EBIT Q2Q % growth | -623.22K 71.93% | 5.277M 445.13% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.26 -550.00% | -0.29 | 0.03 | 8.96% |
| Q1 2025 Q2Q % growth | 0.44 129.73% | -0.35 | 0.79 | 226.87% |
| Q4 2024 Q2Q % growth | -0.82 -38.98% | -0.46 | -0.36 | -78.65% |
| Q3 2024 Q2Q % growth | -0.52 73.06% | -0.65 | 0.13 | 20.34% |
| Q2 2024 Q2Q % growth | -0.04 96.95% | -0.26 | 0.22 | 84.31% |
| Q1 2024 Q2Q % growth | -1.48 -23.33% | -0.04 | -1.44 | -3,527.45% |
| Q4 2023 Q2Q % growth | -0.59 93.98% | -0.97 | 0.38 | 39.11% |
| Q3 2023 Q2Q % growth | -1.93 94.61% | -0.64 | -1.29 | -200.34% |
| Q2 2023 Q2Q % growth | -1.31 85.11% | -1.63 | 0.32 | 19.73% |
| Q1 2023 Q2Q % growth | -1.20 94.50% | -3.67 | 2.47 | 67.32% |
| Q4 2022 Q2Q % growth | -9.80 -1,206.67% | -7.55 | -2.25 | -29.84% |
| Q3 2022 Q2Q % growth | -35.80 -2,439.01% | -8.36 | -27.44 | -328.02% |
| Q2 2022 Q2Q % growth | -8.80 -1,157.14% | -11.83 | 3.03 | 25.63% |
| Q1 2022 Q2Q % growth | -21.80 -5,350.00% | -10.00 | -11.80 | -118.09% |
| Q4 2021 Q2Q % growth | -0.75 -275.00% | -0.50 | -0.25 | -50.06% |
| Q3 2021 Q2Q % growth | -1.41 6.00% | -0.32 | -1.09 | -338.84% |
| Q2 2021 Q2Q % growth | -0.70 -600.00% | -0.45 | -0.25 | -55.97% |
| Q1 2021 Q2Q % growth | -0.40 87.50% | -0.56 | 0.16 | 28.70% |
| Q4 2020 Q2Q % growth | -0.20 93.75% | -0.36 | 0.16 | 43.98% |
| Q3 2020 Q2Q % growth | -1.50 70.00% | -2.24 | 0.74 | 33.16% |
| Q2 2020 Q2Q % growth | -0.10 98.44% | -2.50 | 2.40 | 96.00% |
| Q1 2020 Q2Q % growth | -3.20 83.67% | -2.81 | -0.40 | -14.08% |
| Q4 2019 Q2Q % growth | -3.20 | -3.37 | 0.17 | 4.93% |
| Q3 2019 Q2Q % growth | -5.00 | -5.92 | 0.92 | 15.48% |
| Q2 2019 Q2Q % growth | -6.40 | -4.03 | -2.37 | -58.85% |
| Q1 2019 Q2Q % growth | -19.60 | -14.79 | -4.81 | -32.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 16.221M -29.27% | 15.865M | 356K | 2.24% |
| Q1 2025 Q2Q % growth | 16.574M -25.00% | 14.043M | 2.531M | 18.02% |
| Q4 2024 Q2Q % growth | 17.976M -41.51% | 18.667M | -691K | -3.70% |
| Q3 2024 Q2Q % growth | 17.993M -20.85% | 17.693M | 300K | 1.70% |
| Q2 2024 Q2Q % growth | 22.934M -12.73% | 22.18M | 754K | 3.40% |
| Q1 2024 Q2Q % growth | 22.099M -20.10% | 28.281M | -6.182M | -21.86% |
| Q4 2023 Q2Q % growth | 30.732M 11.96% | 28.248M | 2.484M | 8.79% |
| Q3 2023 Q2Q % growth | 22.733M -6.06% | 28.56M | -5.827M | -20.40% |
| Q2 2023 Q2Q % growth | 26.28M 13.62% | 26.928M | -648K | -2.41% |
| Q1 2023 Q2Q % growth | 27.66M 26.30% | 24.786M | 2.874M | 11.60% |
| Q4 2022 Q2Q % growth | 27.45M 16.91% | 26.01M | 1.44M | 5.54% |
| Q3 2022 Q2Q % growth | 24.2M 79.53% | 25.296M | -1.096M | -4.33% |
| Q2 2022 Q2Q % growth | 23.13M 52.67% | 27.744M | -4.614M | -16.63% |
| Q1 2022 Q2Q % growth | 21.9M 61.98% | 22.542M | -642K | -2.85% |
| Q4 2021 Q2Q % growth | 23.48M 58.01% | 21.318M | 2.162M | 10.14% |
| Q3 2021 Q2Q % growth | 13.48M 65.20% | 14.346M | -866K | -6.04% |
| Q2 2021 Q2Q % growth | 15.15M 376.42% | 12.495M | 2.655M | 21.25% |
| Q1 2021 Q2Q % growth | 13.52M 838.89% | 13.597M | -77K | -0.57% |
| Q4 2020 Q2Q % growth | 14.86M 763.95% | 11.465M | 3.395M | 29.61% |
| Q3 2020 Q2Q % growth | 8.16M 242.86% | 6.533M | 1.627M | 24.90% |
| Q2 2020 Q2Q % growth | 3.18M 76.67% | 2.792M | 388K | 13.90% |
| Q1 2020 Q2Q % growth | 1.44M 0.70% | 2.055M | -615K | -29.93% |
| Q4 2019 Q2Q % growth | 1.72M | 1.811M | -91K | -5.02% |
| Q3 2019 Q2Q % growth | 2.38M | 2.076M | 304K | 14.64% |
| Q2 2019 Q2Q % growth | 1.8M | 1.726M | 74K | 4.29% |
| Q1 2019 Q2Q % growth | 1.43M | 1.352M | 78K | 5.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 20% | 213.04% |
| Revenue | -21.88% | N/A | -4.61% | -0.65% |